special situations · source notes

Deal news.

Developments across tracked transactions and the wider deal market. Concise original summaries, with source links and explicit review status.

← Merger arbitrage table

Snapshot retrieved Oct 12, 2026, 22:30 UTC

Public, editorially approved items only. Coverage may be incomplete. Refresh to retrieve updates.

47 published items · All news

Ordered by source publication date, falling back to fetch time.

Confirmed eventTracked dealreported deal update

Copart extends ACV tender offer to October 15

ACV's Schedule 14D-9/A says Copart's $10.50/share tender offer was further extended to 5:00 p.m. ET on October 15, 2026.

No table update applicable
Event date
Oct 8, 2026
Source published
Oct 9, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
ACV Auctions Schedule 14D-9/A · Copart extends ACV tender offer to October 15 ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:05 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

MITT/CHMI proxy amendment sets December 2 vote

MITT's Form S-4/A sets CHMI's virtual special meeting for December 2, 2026 at 9:00 a.m. ET; no economics or close-timing change was required.

No table update applicable
Event date
Oct 2, 2026
Source published
Oct 9, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
TPG Mortgage Investment Trust Form S-4/A · MITT/CHMI proxy amendment sets December 2 vote ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:05 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealdeal announced

Pacira signs $36.50/share cash tender merger with Viatris

Pacira signed a definitive agreement for Viatris to acquire PCRX via a $36.50/share cash tender offer, followed by a second-step merger; the canonical deal row was added from the SEC filing.

No table update applicable
Event date
Oct 8, 2026
Source published
Oct 9, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
Pacira BioSciences Form 8-K · Pacira signs $36.50/share cash tender merger with Viatris ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:05 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

AkzoNobel portfolio-sale filing references Axalta closing focus

AkzoNobel filed a Rule 425 release announcing Southeast Asia Decorative Paints divestitures and said it will continue to focus on successfully closing the Axalta merger; no Axalta deal terms or dates changed.

No table update applicable
Event date
Oct 5, 2026
Source published
Oct 9, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
SEC EDGAR · AkzoNobel portfolio-sale filing references Axalta closing focus ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:26 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

Synaptics files preliminary proxy for amended onsemi deal

Synaptics filed a preliminary proxy for the amended $123/share cash onsemi merger; meeting and record dates remain blank, so no table mutation was made.

No table update applicable
Event date
Oct 8, 2026
Source published
Oct 9, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
Synaptics preliminary proxy statement · Synaptics files preliminary proxy for amended onsemi deal ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:05 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

Brink's reports CMA remedy acceptance in principle

Brink's says the CMA accepted in principle its proposed NoteMachine/TestLink UK remedy for the NCR Atleos acquisition and that the deal remains on track for early Q1 2027; no canonical terms changed.

No table update applicable
Event date
Oct 8, 2026
Source published
Oct 9, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
Brink's investor release · Brink's reports CMA remedy acceptance in principle ↗
Review and source context

Source type: issuer. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:05 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealissuer update

Recordati tender increase already reflected

Recordati's tender-offer page links the Oct. 6 issuer release raising the offer to EUR 53.00 and extending the acceptance period to Oct. 23; the canonical deal already reflects those facts.

No table update applicable
Event date
Oct 6, 2026
Source published
Not supplied
Source fetched
Oct 8, 2026, 11:00 UTC
Recordati / Respighi BidCo · Recordati tender increase already reflected ↗
Review and source context

Source type: issuer. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 8, 2026, 11:28 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

Centerspace definitive proxy/prospectus confirms vote

Centerspace filed definitive merger proxy materials for the IRT transaction; the tracked 3.800 IRT-share exchange ratio and November 10, 2026 vote date remain unchanged.

No table update applicable
Event date
Oct 7, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 8, 2026, 11:00 UTC
SEC EDGAR · Centerspace definitive proxy/prospectus confirms vote ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:26 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

Cintas and UniFirst complete Second Request compliance

Cintas filed that both parties certified substantial compliance with the FTC Second Request on Oct. 2 and agreed not to close before Dec. 11 absent earlier FTC clearance; Cintas still expects closing before year-end 2026.

No table update applicable
Event date
Oct 6, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 8, 2026, 11:00 UTC
SEC EDGAR / Cintas Form 8-K · Cintas and UniFirst complete Second Request compliance ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 8, 2026, 11:28 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

Atkore holders approve Prysmian merger

Prysmian announced Atkore stockholder approval of the $95.00/share cash merger and now expects closing on Oct. 19, 2026, subject to remaining regulatory clearance and customary conditions.

Table update applied
Event date
Oct 7, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 8, 2026, 11:00 UTC
Prysmian · Atkore holders approve Prysmian merger ↗
Review and source context

Source type: issuer. Source confidence: source reviewed.

Review status: applied. Reviewed at: Oct 8, 2026, 11:28 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

DSG financing-related filing reviewed

Distribution Solutions Group filed transaction-related financing and solicitation material for the LKCM take-private; no source-backed deal-table field changed.

No table update applicable
Event date
Oct 5, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 8, 2026, 11:00 UTC
SEC EDGAR / Distribution Solutions Group DEFA14A · DSG financing-related filing reviewed ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 8, 2026, 11:28 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealfiling update

Synaptics preliminary proxy reflects amended cash merger

Synaptics filed a preliminary proxy for the amended onsemi merger, reiterating $123.00 per share cash consideration; the special-meeting date remains blank, so no watch date or deal-field update was added.

No table update applicable
Event date
Oct 8, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
SEC EDGAR · Synaptics preliminary proxy reflects amended cash merger ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:26 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealfiling update

Atkore gives conditional note-redemption notice tied to merger

Atkore filed a conditional redemption notice for its 4.25% senior notes, with redemption expected October 19, 2026 only if the Prysmian merger closes and funding is provided; the tracked expected close date was already October 19.

No table update applicable
Event date
Oct 8, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
SEC EDGAR · Atkore gives conditional note-redemption notice tied to merger ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:26 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealreported deal update

Clear Channel receives CFIUS clearance

Clear Channel announced CFIUS clearance, said all regulatory requirements have been obtained, and expects the Mubadala Capital acquisition to close on or about Oct. 14, 2026.

Table update applied
Event date
Oct 7, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 8, 2026, 11:00 UTC
Clear Channel Outdoor · Clear Channel receives CFIUS clearance ↗
Review and source context

Source type: issuer. Source confidence: source reviewed.

Review status: applied. Reviewed at: Oct 8, 2026, 11:28 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealfiling update

American Water and Essential issue integration-planning release

American Water and Essential Utilities filed a joint Rule 425 release naming a future Pennsylvania American Water president upon closing; no regulatory approval, closing or economic change was confirmed.

No table update applicable
Event date
Oct 8, 2026
Source published
Oct 8, 2026 · time not supplied
Source fetched
Oct 9, 2026, 11:00 UTC
SEC EDGAR · American Water and Essential issue integration-planning release ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 9, 2026, 11:26 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealissuer update

Respighi BidCo raises Recordati offer and extends tender

Issuer release dated Oct. 6, 2026 raises the Recordati offer to EUR 53.00 per share, extends the acceptance period to Oct. 23, 2026 and sets ordinary-period payment for Nov. 2, 2026.

Table update applied
Event date
Oct 6, 2026
Source published
Not supplied
Source fetched
Oct 7, 2026, 11:00 UTC
Recordati on behalf of Respighi BidCo · Respighi BidCo raises Recordati offer and extends tender ↗
Review and source context

Source type: issuer. Source confidence: source reviewed.

Review status: applied. Reviewed at: Oct 8, 2026, 11:07 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealissuer update

Paramount/WBD completion already reflected in canonical deal

Paramount completion release confirms the Warner Bros. Discovery acquisition closed on Oct. 6, 2026; canonical deal WBD-PSKY-2026 is already terminal, so no fact mutation was needed.

No table update applicable
Event date
Oct 6, 2026
Source published
Oct 7, 2026 · time not supplied
Source fetched
Oct 7, 2026, 11:00 UTC
Paramount Skydance · Paramount/WBD completion already reflected in canonical deal ↗
Review and source context

Source type: issuer. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 8, 2026, 11:05 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealissuer update

Repligen/BioLife completion already reflected in canonical deal

BioLife SEC filing confirms the Repligen acquisition completed on Oct. 6, 2026; canonical deal BLFS-RGEN-2026 is already terminal, so no fact mutation was needed.

No table update applicable
Event date
Oct 6, 2026
Source published
Oct 7, 2026 · time not supplied
Source fetched
Oct 7, 2026, 11:00 UTC
BioLife Solutions SEC filing · Repligen/BioLife completion already reflected in canonical deal ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 8, 2026, 11:06 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealdeal announced

Option Care announcement linked to canonical deal

Option Care Health's SEC filing confirms the signed CD&R/McKesson acquisition already added as OPCH-CDR-MCK-2026; no additional fact change was required.

No table update applicable
Event date
Oct 6, 2026
Source published
Oct 7, 2026 · time not supplied
Source fetched
Oct 8, 2026, 11:00 UTC
SEC EDGAR / Option Care Health Form 8-K · Option Care announcement linked to canonical deal ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 8, 2026, 11:28 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

Confirmed eventTracked dealdeal announced

Option Care Health signed $32.05/share cash take-private agreement

Primary SEC and issuer sources confirm Option Care Health entered a definitive merger agreement with CD&R/McKesson-backed Onyx Bidco for $32.05/share cash; canonical deal row added separately.

No table update applicable
Event date
Oct 6, 2026
Source published
Oct 7, 2026 · time not supplied
Source fetched
Oct 7, 2026, 11:00 UTC
Option Care Health Form 8-K · Option Care Health signed $32.05/share cash take-private agreement ↗
Review and source context

Source type: sec. Source confidence: source reviewed.

Review status: reviewed. Reviewed at: Oct 7, 2026, 17:02 UTC.

A news item does not by itself change the deal table. Fetch time is not the event date or a market quote timestamp.

This feed can change between pages. View the deal table for calculated values and valuation context.